Top 10 AI Tools for Veterinarians

Purpose-built AI clinical assistant that generates structured medical notes directly from doctor-patient conversations, solving a core veterinary workflow pain point that generalist tools cannot address with the same clinical accuracy and compliance focus.

Strong EHR integration across 150+ health systems and 35+ languages with meaningful clinician efficiency gains, but hallucination complaints and cluttered interface concerns, plus opaque pricing, limit the score.

Free tier lacks BAA creating HIPAA risk for PHI-handling practices, training data use ambiguous in publicly unavailable enterprise agreements, and no third-party security certifications confirmed despite healthcare context requiring them.

Impressive adoption with 85,000+ clinicians and 20M+ patient encounters annually across 130+ health organizations, major health system wins in 2026, and a high-profile AI partnership with AMI/Yann LeCun signal strong market traction.

Well-documented Core API with OAuth 2.0 and Postman collection, active 2026 product launches including on-device Mac dictation, but deprecated Care Platform SDKs and absence of active multi-language SDKs limit developer experience depth.

AI voice assistant specifically designed for healthcare practitioners to generate clinical notes from patient conversations, with veterinary-compatible clinical workflows, though primary positioning is human medicine rather than veterinary-specific features.

Suki delivers strong ambient note generation validated by KLAS 93.8/100 and 95% would-buy-again rate, with deep Epic, Oracle Health, athenahealth, and MEDITECH integrations, but high pricing ($299–$399+/month with setup fees, no free tier) and complaints about generic notes and missed medication names constrain the operational score.

HIPAA compliance and SOC 2 Type II certification are confirmed, Google Cloud Vertex AI partnership adds credibility, and BAA availability is standard; no known data breaches or major incidents were identified, though hallucination of medication names is a documented concern.

Suki demonstrates exceptional market traction with 4x growth in 2024 followed by tripling in 2025, $168M raised at ~$500M valuation with a 2024 Series D, 400+ health system partnerships, Epic Toolbox membership, and a Zoom partnership covering 140,000 healthcare organizations globally.

Suki for Partners provides REST APIs, Web SDK, Mobile SDK, and Headless SDK launched June 2024 with developer docs updated July 2026, but access is credentialed rather than self-service, GitHub activity is limited to a third-party API evangelist repo, and orchestration/webhook documentation appears incomplete.

AI-powered search engine with cited sources excels at retrieving current veterinary research, clinical guidelines, and drug information during patient consultations, though it lacks veterinary-specific medical knowledge bases compared to purpose-built veterinary tools.

303 G2 reviews averaging 4.7/5, ease of setup scored 97% and ease of use 95%, with Zapier/Make/Gmail/Slack/Google Drive integrations confirmed and a meaningful free tier — operationally strong across all sub-dimensions with only minor hallucination rates (3.3% benchmark) tempering output reliability.

SOC 2 Type II confirmed alongside GDPR and PCI DSS, zero data retention policy for Sonar API users explicitly documented, and no training on enterprise data; penalized slightly by 25+ minor outages tracked on status page over ~1 year and consumer-tier training data ambiguity.

Raised $200M at $20B valuation in September 2025 with investors including NVIDIA, SoftBank, and Jeff Bezos; ARR grew to ~$200M by February 2026 with 100M+ MAU and 20,000+ enterprise organizations; tier-1 press coverage from TechCrunch and VentureBeat throughout the period.

Official Python (perplexity-py) and Node (perplexity-node) SDKs on GitHub with active commits as recently as January 2026 and changelog updated May 2026; LangChain and LlamaIndex integrations confirmed via AI SDK providers; Sonar API is versioned with full auth docs, though full OpenAPI spec availability and SLA documentation have minor gaps.

Superior medical translation accuracy enables veterinarians to serve multilingual clients and access international veterinary literature, but lacks healthcare-specific terminology optimization and medical context awareness compared to medical translation systems.

DeepL delivers highly praised translation accuracy with 4.6/5 G2 and 4.8/5 Capterra ratings, meaningful free tier, and easy onboarding, but narrower language coverage (33 vs Google's 130+) and mobile app friction limit its universal utility score.

Privacy posture is reasonable for a German-headquartered company subject to GDPR, but no explicit SOC 2 certification evidence was found in research, Trustpilot score is a concerning 2.4/5, and customer support quality draws repeated complaints about unresponsiveness.

DeepL demonstrates strong market signals with $400M+ raised at a $2B valuation led by Index Ventures, 200,000+ business customers including Zendesk and Coursera, and active expansion into 60+ markets, though G2 review count at 167 is modest for its scale.

The June 2026 API modernization, Voice API with WebSocket streaming, and a free API tier with 500K chars/month show solid developer investment, but undocumented rate limits that surprise production users and gaps in SDK breadth prevent a higher score.

Meeting summaries and recordings support telemedicine consultations and staff training, but the tool is healthcare-agnostic without veterinary-specific features like encrypted storage or HIPAA compliance documentation that veterinary practices require.

Zoom AI Companion is well-integrated into a widely-used platform with meeting summaries, chat drafting, and recall features included at no extra cost on paid plans, but reliability concerns around casual conversation handling, occasional oversharing of private comments, and a free tier capped at 3 AI notes/month limit full-confidence scoring.

Zoom is a mature enterprise platform with expected security certifications, but evidence shows ambiguity around AI training data opt-out, a noted pattern of AI-generated reviews on G2 inflating ratings, and customer support friction that raises transparency concerns.

Zoom remains the dominant video conferencing platform with strong ecosystem signals, active product updates through August 2026, federation with major AI models (Claude, GPT-5.1, Gemini), and marketplace presence, though significant pricing volatility (45% increase then 37% decrease) and hidden add-on costs temper enthusiasm.

Zoom offers a versioned REST API (v2), JavaScript Apps SDK, Meeting SDK, and MCP server support added in June 2026, with active development evidenced by multiple 2026 releases, though the API lacks in-meeting controls and has no CORS support, limiting some developer use cases.

AI customer support agent can handle pet owner FAQs (vaccinations, aftercare, appointment booking) reducing administrative burden, but it lacks veterinary-specific knowledge and cannot handle clinical triage or medical decision support.

Fin earns strong operational scores via 3,855+ G2 reviews averaging 4.5/5 and credible ticket deflection claims, but disputed 'resolution by silence' billing logic, limited analytics granularity, and opaque pricing complexity prevent a top-tier score.

No confirmed data breaches and a readable privacy posture support moderate trust, but ambiguous training data use, Trustpilot score of 2.9/5, disputed resolution inference billing, and absent SOC 2 evidence in the research data cap the score.

The $3.6B Salesforce acquisition, #1 G2 AI Agent ranking by review volume, 3,855+ reviews with active recent posting, and 76% autonomous resolution claims across the customer base signal exceptional market traction and ecosystem validation.

REST API v2.16 with OpenAPI spec and interactive docs is solid, but the spec was last updated October 2025, SDKs are limited to iOS and Rails, OpenAPI generators are unsupported, and orchestration readiness (LangChain/MCP) is not documented in available evidence.

Improves clarity of clinical notes and client communications to reduce misunderstandings about treatment plans, but provides no veterinary terminology support or clinical documentation standards awareness that healthcare-specific writing tools offer.

Grammarly scores strongly on core task utility with 4.7/5 on G2 across nearly 13K reviews and consistent praise for real-time grammar and clarity improvements, but reliability docks due to documented overcorrection complaints, context struggles, and the controversial Expert Review feature being discontinued in March 2026; free tier is meaningfully limited (100 AI prompts/month) and the $144/year annual commitment creates ROI friction versus alternatives.

Privacy posture is not explicitly confirmed as training-opt-out in the evidence, GDPR status is unverified in supplied data, and security certifications are not documented in the evidence; widespread auto-renewal complaints and non-refundable payment terms damage user trust signals, though no confirmed data breach was found.

Grammarly demonstrates exceptional market adoption with 12,969 G2 reviews at 4.7/5, 10K+ Trustpilot reviews, 181K+ App Store reviews, a $13B valuation maintained through 2025, $1.55B+ total funding from tier-1 VCs, and an aggressive acquisition strategy (Coda, Superhuman, Rows) signaling strong ecosystem expansion momentum.

Developer API is enterprise/organization-focused with limited developer surface area — no SDK documentation found, no public GitHub activity retrieved, no OpenAPI spec evidence, and the documentation explicitly notes that teams needing proofreading-as-API often look elsewhere; consumer tool baseline applies but enterprise API gaps are real.

Free meeting recording and CRM auto-fill accelerates client notes entry during consultations, but lacks veterinary-specific data fields (pet species, medical history templates, diagnostic codes) that would make it truly optimized for practice management.

Fathom delivers exceptional core task utility with near-perfect G2 ratings across 6,600 reviews, strong CRM integrations with HubSpot and Salesforce, and reliable 30-second post-meeting summaries, though free-tier AI summaries were capped at 5/month as of June 2026, reducing ROI accessibility slightly.

Privacy posture is adequate with GDPR signals but no confirmed SOC 2 Type II, no explicit HIPAA compliance or BAA availability, and training data opt-out status is ambiguous, creating meaningful gaps for regulated industries.

Fathom shows exceptional adoption velocity with 6,600 G2 reviews and a 5.0 rating, $61M total funding with a May 2026 undisclosed round from Google Ventures, though it skews heavily toward SMB (78% small business) limiting enterprise ecosystem signals.

Developer docs at developers.fathom.ai confirm REST API, webhook support, and TypeScript/Python SDKs, but GitHub activity is limited, changelog last updated February 2026, and rate limits and OpenAPI spec availability are not confirmed.

Generalist AI can assist with client communication templates, continuing education research, and practice management questions, but lacks veterinary clinical knowledge, medical compliance awareness, and should never substitute for veterinary-specific decision support systems.

ChatGPT scores highly across core task utility (top-tier reasoning, research, and agentic tasks confirmed in 2026 independent tests) with G2 4.7/5 from 2,000+ reviews and 96% ease-of-use satisfaction, tempered slightly by hallucination caveats and increasingly complex pricing tiers that obscure model access by plan.

Free/Go/Plus/Pro tiers use content to train models with opt-out available but not prominently disclosed, privacy posture is mixed; Trustpilot 1.6/5 from 2,800 reviews driven heavily by billing disputes and quality grievances signals real consumer trust erosion, though business-tier data protections are stronger; no confirmed breach but incident transparency infrastructure is limited.

ChatGPT is the dominant AI assistant by virtually every adoption metric — 6.7M App Store reviews at 4.8/5, 2,000+ G2 reviews growing, GPT-6 Astra launched September 2026, Microsoft Word integration rolling out October 2026, and OpenAI's funding and enterprise momentum are unmatched in the category.

OpenAI shipped more developer infrastructure in H1 2026 than the prior two years combined, with versioned APIs, official SDKs for Python, Node, Go, Ruby, and Java, OAuth and plugin platform improvements through August 2026, and GPT-6 Astra API pricing published; minor gaps in SLA transparency and rate limit documentation prevent a higher score.